TrialPloS one2020

Unique referral system contributes to long-term net clinical benefits in patients undergoing secondary prevention therapy after percutaneous coronary intervention.

Shigetaka Kageyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.